FBMPX
Price
$142.43
Change
-$1.70 (-1.18%)
Updated
Jun 2 closing price
Net Assets
2.85B
VTCAX
Price
$97.89
Change
-$1.42 (-1.43%)
Updated
Jun 2 closing price
Net Assets
6.32B
Interact to see
Advertisement

FBMPX vs VTCAX

Header iconFBMPX vs VTCAX Comparison
Open Charts FBMPX vs VTCAXBanner chart's image
FBMPX vs VTCAX Comparison Chart in %
View a ticker or compare two or three
VS
FBMPX vs. VTCAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBMPX is a Hold and VTCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTCAX has more cash in the bank: 6.32B vs. FBMPX (2.85B). VTCAX pays higher dividends than FBMPX: VTCAX (0.96) vs FBMPX (0.00). FBMPX was incepted earlier than VTCAX: FBMPX (40 years) vs VTCAX (21 years). FBMPX (0.64) is less costly to investors than VTCAX (0.09). FBMPX is a more actively managed with annual turnover of: 147.00 vs. VTCAX (12.00). FBMPX has a lower initial minimum investment than VTCAX: FBMPX (0) vs VTCAX (100000). FBMPX annual gain was more profitable for investors over the last year : 24.39 vs. VTCAX (21.64). FBMPX return over 5 years is better than : 54.18 vs. VTCAX (41.83).
FBMPXVTCAXFBMPX / VTCAX
Total Expense Ratio0.640.09711%
Annual Report Gross Expense Ratio0.640.09711%
Fund Existence40 years21 years-
Gain YTD3.2890.659499%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRA500N/A-
Net Assets2.85B6.32B45%
Annual Yield % from dividends0.000.96-
Returns for 1 year24.3921.64113%
Returns for 3 years95.1789.49106%
Returns for 5 years54.1841.83130%
Returns for 10 years100.04114.1988%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZBAO0.910.09
+10.97%
Zhibao Technology
AFRI9.97-0.01
-0.10%
Forafric Global PLC
BNY141.28-1.31
-0.92%
Bank of New York Mellon Corp.
TNDM18.61-0.51
-2.67%
Tandem Diabetes Care
KYMR71.29-7.18
-9.15%
Kymera Therapeutics